Bright Minds Biosciences Inc (DRUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2024 | 09-2023 | 09-2022 | 09-2021 | 12-2020 | |
| Operating Expenses | 2,075 | 5,477 | 11,724 | 6,954 | 1,957 |
| Operating Income | -2,075 | -5,477 | -11,724 | -6,954 | -1,957 |
| Other Income | 15 | 11 | 8 | 107 | -4,890 |
| Pre-tax Income | -2,059 | -5,467 | -11,716 | -6,847 | -6,847 |
| Net Income Continuous | -2,059 | -5,467 | -11,716 | -6,847 | -6,847 |
| Net Income | $-2,059 | $-5,467 | $-11,716 | $-6,847 | $-6,847 |
| EPS Basic Total Ops | -0.48 | -1.47 | -4.74 | -3.82 | N/A |
| EPS Basic Continuous Ops | -0.48 | -1.47 | -4.74 | -3.82 | N/A |
| EPS Diluted Total Ops | -0.48 | -1.47 | -4.74 | -3.82 | N/A |
| EPS Diluted Continuous Ops | -0.48 | -1.47 | -4.74 | -3.82 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.48 | -1.47 | -4.75 | -3.80 | N/A |
| EBITDA(a) | $-2,021 | $-5,423 | $-11,719 | $-6,954 | $-1,957 |